サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684382

くも膜嚢胞治療の世界市場：タイプ別、診断別、治療別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2025年～2032年）

Arachnoid Cysts Treatment Market, By Type, By Diagnosis, By Treatment, By End-User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
くも膜嚢胞治療の世界市場：タイプ別、診断別、治療別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2025年～2032年）
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

世界のくも膜嚢胞治療の市場規模は、2024年に15億343万米ドルとなり、2025年～2032年にCAGR5.90%で拡大する見込みです。

くも膜嚢胞治療市場：市場力学

神経学的研究と治療開発への資金提供の増加

神経学的研究と治療開発のための資金提供の増加は、くも膜嚢胞治療市場の主要な促進要因です。政府と民間の両方からの財政支援により、新しい治療法や技術の発見が加速し、患者の転帰が改善されています。これらの資金により、大学や研究機関は臨床試験を実施し、革新的な手術技術を開発し、くも膜嚢胞に合わせた薬物療法を探求することができます。

米国国立衛生研究所（NIH）は、2023年に神経学研究に20億米ドル以上を割り当てており、脳・脊髄疾患への取り組みが進んでいることを強調しています。この投資により、研究機関、医療関係者、製薬企業間の協力が促進され、診断の精度や治療の選択肢が向上します。さらに、資金提供の増加は、インフラやトレーニングプログラムの改善につながり、ヘルスケアの人材がこのような症状に効果的に対処できるようになります。結局のところ、この分野における資金提供の拡大は、嚢胞管理の未来を形成し、患者により個別化されたケアソリューションを提供することになります。

くも膜嚢胞治療市場：主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025～2032年）に約5.90％のCAGRで毎年成長すると推定されています。

タイプ別では、頭蓋内が2024年に最大市場シェアを示すと予測されていました。

診断別では、2024年にMRI検査が主要な診断となりました。

治療別では、2024年に内視鏡的嚢胞開窓術が主要治療でした。

エンドユーザー別では、病院が2024年の主要エンドユーザーでした。

地域別では、北米が2024年の売上高でトップでした。

くも膜嚢胞治療市場：セグメンテーション分析

世界のくも膜嚢胞治療市場は、タイプ、診断、治療、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプ別に4つのカテゴリーに分けられ、頭蓋内、脊髄、永久ドレナージシステム手術、内視鏡的嚢胞開窓術です。 くも膜嚢胞治療市場では、頭蓋内が最も重要かつ支配的なセグメントです。これは、ほとんどのくも膜嚢胞が脳内にあり、圧力を緩和し神経障害を防ぐために外科的介入が必要であるという事実によるものです。嚢胞切除やドレナージなどの頭蓋内手術は、症候性嚢胞の治療や水頭症などの合併症の管理のために一般的に行われています。脳神経外科技術における認知度の向上と進歩が、頭蓋内くも膜嚢胞の効果的な治療におけるこのセグメントの重要性をさらに高めています。

市場は診断別に4つのカテゴリーに分けられ、CTスキャン、MRIスキャン、出生前超音波検査、その他です。 くも膜嚢胞治療市場では、MRIスキャンが最も著名な診断セグメントです。MRIは解像度が高く、脳や脊髄内の嚢胞やその大きさ、位置を明確に可視化できるため、好まれる画像診断法です。この非侵襲的な技術は、優れた軟部組織のコントラストを提供し、嚢胞の正確な診断と進行のモニタリングを可能にします。MRIは、水頭症などの潜在的な合併症を特定する能力があり、くも膜嚢胞の診断プロセスにおける優位性をさらに強固なものにしています。

市場は治療別に3つのカテゴリーに分けられ、永久ドレナージシステム手術、開窓術、内視鏡的嚢胞開窓術です。 くも膜嚢胞の治療法の中では、内視鏡的嚢胞開窓術が最も重要かつ支配的な治療法です。この低侵襲的手技は、内視鏡を用いて嚢胞壁に開口部を形成し、嚢胞が周囲の空間に排出されるようにすることで、圧迫を軽減するものです。特に外科的治療が困難な嚢胞に対して、回復が早く、合併症のリスクが少なく、長期的に効果的な結果が得られるため、好まれています。内視鏡下嚢胞開窓術は、従来の方法と比較して精度が高く、外傷が少ないことから人気を博しており、多くの脳神経外科医にとって最適な選択肢となっています。

くも膜嚢胞治療市場：地理的洞察

北米のくも膜嚢胞治療市場は、先進的なヘルスケアインフラ、神経疾患に対する高い認知度、医学研究への多額の投資によって牽引されています。特に米国は、その強固なヘルスケアシステム、継続的な治療技術の革新、新しい治療法のための多数の臨床試験により、この地域を支配しています。カナダも、強力なヘルスケア体制とくも膜嚢胞の診断率上昇の恩恵を受けており、大きく貢献しています。画像診断と低侵襲手術の技術的進歩により、診断と治療の選択肢が改善され、市場の成長を後押ししています。さらに、高齢者人口の増加と神経学的疾患の増加も、この地域における効果的な治療オプションの需要をさらに後押ししています。

米国は北米のくも膜嚢胞治療市場において支配的な国であり、世界有数のヘルスケアインフラと充実した研究資金がその原動力となっています。同国には多数の専門医療センターと高度な診断ツールがあり、くも膜嚢胞の早期発見と的確な治療を可能にしています。米国では臨床試験や技術革新も盛んで、新しい治療法の開発に貢献しています。さらに、人口が多く、神経疾患の有病率が高いことも、市場の成長をさらに後押ししています。

くも膜嚢胞治療市場：競合情勢

くも膜嚢胞治療市場の競合情勢は、既存の医療機器メーカー、ヘルスケア提供者、製薬会社が混在していることが特徴です。メドトロニック、ストライカー、ジョンソン・エンド・ジョンソンなどの主要企業は、手術器具や治療ソリューションの強力なポートフォリオで市場を独占しています。低侵襲手術技術や画像処理システムの強化といった技術の進歩が、企業間の激しい競合を助長しています。個別化治療やより効果的な診断ツールの需要が高まる中、革新的なソリューションを持つ中小企業や新興企業も台頭してきています。研究開発のための提携や協力は一般的で、各社の製品提供の拡大に役立っています。さらに、ロボット支援手術の採用拡大や神経外科用機器の進歩により、競争企業間の敵対関係が激化することが予想されます。各社はまた、競争優位性を獲得するために、患者の転帰を改善し、回復時間を短縮することに注力しています。

目次

第1章 くも膜嚢胞治療市場の概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 くも膜嚢胞治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 くも膜嚢胞治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 くも膜嚢胞治療市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 くも膜嚢胞治療の市場情勢

  • くも膜嚢胞治療市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 くも膜嚢胞治療市場：タイプ別

  • 概要
    • セグメントシェア分析：タイプ別
    • 頭蓋内
    • 脊髄
    • 永久ドレナージシステム手術
    • 内視鏡的嚢胞開窓術

第8章 くも膜嚢胞治療市場：診断別

  • 概要
    • セグメントシェア分析：診断別
    • CTスキャン
    • MRIスキャン
    • 出生前超音波検査
    • その他

第9章 くも膜嚢胞治療市場：治療別

  • 概要
    • セグメントシェア分析：治療別
    • 永久ドレナージシステム手術
    • 開窓術
    • 内視鏡的嚢胞開窓術

第10章 くも膜嚢胞治療市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 病院
    • クリニック
    • その他

第11章 くも膜嚢胞治療市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：くも膜嚢胞治療業界

  • 競合ダッシュボード
    • 競合ベンチマーキング
    • 競合ポジショニング
  • 企業プロファイル
    • Medtronic
    • Johnson &Johnson
    • Stryker Corporation
    • Siemens Healthineers
    • GE Healthcare
    • Philips Healthcare
    • Brainlab
    • Terumo Corporation
    • Toshiba Medical Systems
    • Hitachi Medical Corporation
    • Abbott Laboratories
    • Integra LifeSciences
    • NuVasive
    • Boston Scientific Corporation
    • Baxter International
    • Becton, Dickinson and Company
    • Zimmer Biomet
    • DePuy Synthes

第13章 アナリストの全方位展望

目次
Product Code: ANV4891

REPORT HIGHLIGHT

Arachnoid Cysts Treatment Market size was valued at US$ 1,503.43 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

The Arachnoid Cysts Treatment Market refers to the healthcare sector focused on addressing arachnoid cysts, which are fluid-filled sacs that form between the brain or spinal cord and the arachnoid membrane. These cysts can sometimes lead to symptoms like headaches, seizures, and neurological deficits, requiring medical intervention. Treatment options vary from monitoring asymptomatic cysts to surgical interventions, including drainage procedures or cyst removal. The market includes diagnostic tools, pharmaceuticals, and surgical technologies used for treating these cysts. It is driven by the increasing prevalence of neurological disorders, advancements in imaging technologies, and growing awareness of early detection. The market is expanding with a focus on minimally invasive treatment methods and personalized medicine. Factors such as healthcare infrastructure, technological innovations, and the rising demand for effective treatments contribute to market growth.

Arachnoid Cysts Treatment Market- Market Dynamics

Increased funding for neurological research and treatment development

Increased funding for neurological research and treatment development is a key driver for the arachnoid cyst treatment market. Financial support from both government and private sectors has accelerated the discovery of new treatment methods and technologies, improving outcomes for patients. These funds enable universities and research organizations to conduct clinical trials, develop innovative surgical techniques, and explore drug therapies tailored to arachnoid cysts.

The National Institutes of Health (NIH) allocated over $2 billion in 2023 for neurological research, highlighting the growing commitment to addressing brain and spinal cord disorders. This investment fosters collaborations between research institutions, medical professionals, and pharmaceutical companies, enhancing diagnostic precision and treatment options. Further, increased funding leads to better infrastructure and training programs, ensuring the healthcare workforce is equipped to handle such conditions effectively. Ultimately, the growing financial commitment in this space is shaping the future of cyst management and providing patients with more personalized care solutions.

Arachnoid Cysts Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)

Based on Type segmentation, Intracranial was predicted to show maximum market share in the year 2024

Based on Diagnosis segmentation, MRI Scan was the leading Diagnosis in 2024

Based on Treatment segmentation, Endoscopic Cyst Fenestration was the leading Treatment in 2024

Based on End-User segmentation, Hospitals was the leading End-User in 2024

On the basis of region, North America was the leading revenue generator in 2024

Arachnoid Cysts Treatment Market- Segmentation Analysis:

The Global Arachnoid Cysts Treatment Market is segmented on the basis of Type, Diagnosis, Treatment, End-User, and Region.

The market is divided into four categories based on Type: Intracranial, Spinal, Permanent Drainage System Surgery, and Endoscopic Cyst Fenestration. In the Arachnoid Cysts Treatment Market, Intracranial is the most significant and dominant segment. This is due to the fact that most arachnoid cysts are located in the brain, requiring surgical intervention to alleviate pressure and prevent neurological damage. Intracranial surgeries, such as cyst excision or drainage, are commonly performed to treat symptomatic cysts and manage complications like hydrocephalus. The increasing awareness and advancements in neurosurgical techniques have further enhanced the prominence of this segment in treating intracranial arachnoid cysts effectively.

The market is divided into four categories based on Diagnosis: CT Scan, MRI Scan, Prenatal Ultrasound, and Others. In the Arachnoid Cysts Treatment Market, MRI Scan is the most prominent diagnostic segment. MRI is the preferred imaging method due to its high resolution and ability to clearly visualize the cysts, their size, and location within the brain or spinal cord. This non-invasive technique offers superior soft tissue contrast, allowing for accurate diagnosis and monitoring of the cyst's progression. MRI's ability to identify potential complications, such as hydrocephalus, further solidifies its dominance in the diagnostic process for arachnoid cysts.

The market is divided into three categories based on Treatment: Permanent Drainage System Surgery, Fenestration, and Endoscopic Cyst Fenestration. Among the treatment options for arachnoid cysts, Endoscopic Cyst Fenestration is the most significant and dominant procedure. This minimally invasive technique involves using an endoscope to create an opening in the cyst wall, allowing the cyst to drain into surrounding spaces, thereby reducing pressure. It is preferred because it offers a quicker recovery time, reduced risk of complications, and effective long-term results, particularly for cysts that are difficult to treat surgically. Endoscopic cyst fenestration has gained popularity due to its precision and lower trauma compared to traditional methods, making it the go-to option for many neurosurgeons.

Arachnoid Cysts Treatment Market- Geographical Insights

The North American arachnoid cyst treatment market is driven by a combination of advanced healthcare infrastructure, high awareness about neurological disorders, and significant investments in medical research. The United States, in particular, dominates the region due to its robust healthcare system, ongoing innovations in treatment techniques, and a large number of clinical trials for new therapies. Canada also contributes significantly, benefiting from a strong healthcare framework and increasing diagnosis rates of arachnoid cysts. Technological advancements in imaging and minimally invasive surgery have improved diagnosis and treatment options, boosting the market growth. Additionally, the rise in the geriatric population and increasing incidences of neurological conditions further support the demand for effective treatment options in this region.

The United States is the dominant country in the North American arachnoid cyst treatment market, driven by its world-leading healthcare infrastructure and substantial research funding. The country is home to numerous specialized medical centers and advanced diagnostic tools, which enable early detection and precise treatment of arachnoid cysts. The U.S. also sees a high volume of clinical trials and technological innovations, contributing to the development of new treatment options. Furthermore, its large population and higher prevalence of neurological conditions further support the market's growth.

Arachnoid Cysts Treatment Market- Competitive Landscape:

The competitive landscape of the Arachnoid Cysts Treatment Market is characterized by a mix of established medical device manufacturers, healthcare providers, and pharmaceutical companies. Key players like Medtronic, Stryker, and Johnson & Johnson dominate the market with a strong portfolio of surgical instruments and treatment solutions. Technological advancements, such as minimally invasive surgical techniques and enhanced imaging systems, have fostered intense competition among companies. With growing demand for personalized treatments and more effective diagnostic tools, smaller players and startups are also emerging with innovative solutions. Partnerships and collaborations for research and development are common, helping companies expand their product offerings. Additionally, the increasing adoption of robotic-assisted surgeries and advancements in neurosurgical devices are expected to intensify the competitive rivalry. Companies are also focusing on improving patient outcomes and reducing recovery times to gain a competitive edge.

Recent Developments:

In February 2024, Royal Philips, in collaboration with Synthetic MR, a company specializing in MRI software solutions, introduced Smart Quant Neuro 3D. This innovative tool marked a major advancement in providing objective decision support for diagnosing and assessing treatment options for brain disorders such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARACHNOID CYSTS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Brainlab
  • Terumo Corporation
  • Toshiba Medical Systems
  • Hitachi Medical Corporation
  • Abbott Laboratories
  • Integra LifeSciences
  • NuVasive
  • Boston Scientific Corporation
  • Baxter International
  • Becton, Dickinson and Company
  • Zimmer Biomet
  • DePuy Synthes

GLOBALARACHNOID CYSTS TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Intracranial
  • Spinal
  • Permanent Drainage System Surgery
  • Endoscopic Cyst Fenestration

GLOBAL ARACHNOID CYSTS TREATMENT MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • CT Scan
  • MRI Scan
  • Prenatal Ultrasound
  • Others

GLOBAL ARACHNOID CYSTS TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Permanent Drainage System Surgery
  • Fenestration
  • Endoscopic Cyst Fenestration

GLOBAL ARACHNOID CYSTS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL ARACHNOID CYSTS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Arachnoid Cysts Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Arachnoid Cysts Treatment Market Snippet by Type
    • 2.1.2. Arachnoid Cysts Treatment Market Snippet by Diagnosis
    • 2.1.3. Arachnoid Cysts Treatment Market Snippet by Treatment
    • 2.1.4. Arachnoid Cysts Treatment Market Snippet by End-User
    • 2.1.5. Arachnoid Cysts Treatment Market Snippet by Country
    • 2.1.6. Arachnoid Cysts Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Arachnoid Cysts Treatment Key Market Trends

  • 3.1. Arachnoid Cysts Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Arachnoid Cysts Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Arachnoid Cysts Treatment Market Opportunities
  • 3.4. Arachnoid Cysts Treatment Market Future Trends

4. Arachnoid Cysts Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Arachnoid Cysts Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Arachnoid Cysts Treatment Market Landscape

  • 6.1. Arachnoid Cysts Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Arachnoid Cysts Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Intracranial
    • 7.1.3. Spinal
    • 7.1.4. Permanent Drainage System Surgery
    • 7.1.5. Endoscopic Cyst Fenestration

8. Arachnoid Cysts Treatment Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
    • 8.1.2. CT Scan
    • 8.1.3. MRI Scan
    • 8.1.4. Prenatal Ultrasound
    • 8.1.5. Others

9. Arachnoid Cysts Treatment Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2024 & 2032 (%)
    • 9.1.2. Permanent Drainage System Surgery
    • 9.1.3. Fenestration
    • 9.1.4. Endoscopic Cyst Fenestration

10. Arachnoid Cysts Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Others

11. Arachnoid Cysts Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Arachnoid Cysts Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Arachnoid Cysts Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Arachnoid Cysts Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Arachnoid Cysts Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Arachnoid Cysts Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Arachnoid Cysts Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Medtronic
    • 12.2.2. Johnson & Johnson
    • 12.2.3. Stryker Corporation
    • 12.2.4. Siemens Healthineers
    • 12.2.5. GE Healthcare
    • 12.2.6. Philips Healthcare
    • 12.2.7. Brainlab
    • 12.2.8. Terumo Corporation
    • 12.2.9. Toshiba Medical Systems
    • 12.2.10. Hitachi Medical Corporation
    • 12.2.11. Abbott Laboratories
    • 12.2.12. Integra LifeSciences
    • 12.2.13. NuVasive
    • 12.2.14. Boston Scientific Corporation
    • 12.2.15. Baxter International
    • 12.2.16. Becton, Dickinson and Company
    • 12.2.17. Zimmer Biomet
    • 12.2.18. DePuy Synthes

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us